Licensed U.S. Retail Desk — MemoHoney Lot MEM-26/ME-4830 60-day window from purchase Orders and refunds +1 (302) 200-3480

MemoHoney Official Website › Disclaimer

Disclaimer

MemoHoney disclaimer: the claims ceiling and the money

This is a dietary supplement, not a drug. It is not FDA-approved and it is not intended to diagnose, treat, cure or prevent any disease. This desk is paid when a reader buys through it, and no trial of this capsule exists on any cognitive outcome. All three facts are printed on every page that touches them.

Three disclosures that belong at the front of a commercial page rather than the back of it.

Regulatory status

What MemoHoney is, in regulatory terms

A dietary supplement sold in the United States. Supplements may make structure and function claims, which describe what a nutrient supports, and may not make disease claims (the FDA's questions and answers on dietary supplements). Advanced memory support is the first kind. Treating memory loss would be the second, and no page here says it.

The FDA does not approve dietary supplements before sale. A registered facility emblem, which this product ships, means the plant has filed a registration with the regulator. It does not mean the product was reviewed, and no emblem on any bottle can mean that.

The practical reading for a buyer: everything this bottle is allowed to claim is on its own front label, in six short lines, and anything a page adds beyond those lines belongs to the page rather than to the product.

Precautions

The MemoHoney precautions, in one list

  • The form is a capsule swallowed with water. Not a gummy, not a powder, not drops, and a supplement rather than a medicine.
  • The FDA does not approve dietary supplements, and nothing in this bottle is intended to diagnose, treat, cure or prevent a disease of any kind.
  • Eighteen and over, and healthy. The label draws that line and this desk holds it.
  • The Supplement Facts panel lists seven ingredients with an amount beside each one. The seller's advertising names six of them; the seventh is 18 mg of calcium.
  • A noticed change in memory earns one proper assessment. Spending half a year on a capsule first spends half a year.
  • Take what the bottle says. Not more, unless somebody who knows your history and your medicines tells you otherwise.
  • Outcomes vary because people do. Sleep, hearing, blood pressure and movement all pull on the same thing this formula is sold for, and each of the four has randomised evidence that the capsule has not.
  • The star score, the review count and the order total come from the distributor. They summarise its own sales, nobody has audited them, and they are not findings about a formula.
  • Lot MEM-26/ME-4830 names a production run. MEM-4830-26-ME names a filing. A run and a filing are not a laboratory result.
  • The website address on these pages is answered by an editor. It cannot see an order, so a refund begins with a telephone call rather than an email.
  • A refund window is a commitment about money and nothing else. It makes no statement about what a capsule does.

Eleven lines, and none of them is a surprise if you have read the rest of the site. They are collected here because a legal page is where a reader expects to find them, and because scattering the same caution through twenty-five pages is how a supplement starts reading like a prescription.

Honest limits

What this desk does not know about MemoHoney

  • Whether a given run contains the amounts its panel states. Only a certificate of analysis for the lot could show that.
  • What the filing behind reference MEM-4830-26-ME says. This desk has not seen the document and will not describe it.
  • Where the ingredients were sourced. The label says globally sourced and names no country for any of them.
  • Which physician formulated it. No name appears on the label or on the seller's page.
  • What the capsule does. No trial of it exists on any outcome, and the ingredient trials that do exist are in exercise research at gram amounts, where the capsule carries milligrams.

Five unknowns, printed as a list because a commercial page that publishes its own gaps is easier to check than one that does not. Four of the five have the same answer: ring +1 (302) 200-3480 and ask the seller, who is the party that holds them.

The fifth cannot be answered by anybody until somebody runs a trial.

The line

When to stop reading about MemoHoney and see somebody

This is the one paragraph on this website that outranks the rest of it

Where recall has shifted enough for somebody close to you to remark on it, one proper look comes before six months of anything else. MedlinePlus lists what a clinician will want to hear about. A supplement is not a way of finding out, and no page here will pretend that it is.

The reason it sits on the disclaimer rather than only in the footer is that the disclaimer is where a worried reader tends to arrive when they are checking whether a product is legitimate.

Things with randomised evidence behind them in this field include treating hearing loss (the ACHIEVE hearing trial), treating blood pressure (SPRINT MIND) and sleep (a 2026 review of sleep and memory consolidation). None is sold here.

Sources and byline

Sources behind this MemoHoney disclaimer

  1. Questions and Answers on Dietary Supplements. U.S. Food and Drug Administration. https://www.fda.gov/food/information-consumers-using-dietary-supplements/questions-and-answers-dietary-supplements
  2. Using Dietary Supplements Wisely. National Center for Complementary and Integrative Health, National Institutes of Health. https://www.nccih.nih.gov/health/using-dietary-supplements-wisely
  3. Memory. MedlinePlus, U.S. National Library of Medicine. https://medlineplus.gov/memory.html
  4. Lin FR, Pike JR, Albert MS, et al. Hearing intervention versus health education control to reduce cognitive decline in older adults with hearing loss in the USA (ACHIEVE): a multicentre, randomised controlled trial. Lancet. 2023;402(10404):786-797. PMID 37478886. https://pubmed.ncbi.nlm.nih.gov/37478886/
  5. Williamson JD, Pajewski NM, Auchus AP, et al. Effect of Intensive vs Standard Blood Pressure Control on Probable Dementia: A Randomized Clinical Trial. JAMA. 2019;321(6):553-561. PMID 30688979. https://pubmed.ncbi.nlm.nih.gov/30688979/
  6. Yasser E, Ayache L, El Khayat H, et al. Sleep and memory consolidation: Neural and cognitive perspectives. Prog Brain Res. 2026;299:137-176. PMID 42547206. https://pubmed.ncbi.nlm.nih.gov/42547206/
The MemoHoney bottle, front label, 30 capsules

Order MemoHoney with the disclosures read

A dietary supplement, sold by a desk that is paid when you buy, with no trial behind the capsule and 60 days from the date you pay to change your mind.

Two bottles $158 · six bottles $294 · 60 days from purchase to change your mind

Order MemoHoney From This Desk

Lot MEM-26/ME-4830 · 30 capsules a bottle · dispatched inside the United States

60-day money-back guarantee

Two months to decide, counted from the day you pay

Purchase comes first and dispatch comes after it, so a window measured from purchase is the shorter of the two ways to count and it is the one printed here. Sixty days is two bottles at one capsule a morning — long enough to find out whether the routine sticks, and the reason the entry pack and the window are the same length. Claims start on the order line with the order ID in front of you, and the refund policy sets out the five steps that follow.

Order MemoHoney From This Desk

Lot MEM-26/ME-4830 · from $49 a bottle · read the guarantee first

The MemoHoney six-bottle pack with the front labels showing
MemoHoney · one capsule each morning $49 a bottle on the six · 60 days from purchase to change your mind
Add To Cart